Substance active (DCI)
- crisantaspase recombinante
Informations techniques
Exploitant
JAZZ PHARMACEUTICALS
Présentation
ENRYLAZE 10 mg/0,5 mL, solution injectable / pour perfusion
3 flacons en verre de 0,5 ml (CIP : 34009 550 986 8 3)
eNq9WF1z2jAQfOdXePxumwApTseQaWnSMpNMKYFppy8ZYR9BVEjOSeYjv74yJi107CYRUd6wZPbOur29HUXn6wVzloCSCt5xT/y66wCPRUL5Xccdjy690D3v1qI5WRInZkTKjpv/9idAuPR/XF99Av02oNutOZGYzCFWB+9lijL/C5Gza5Lm7zjRUtDEWYCaiaTjppnarjqRVKhjdlcCf8mUxBAFu5X93flta389CnKwZ6BmEvCK8LtS0CkaYcYZInDVIwruBG7KoePbRth+V6+HRiGoHIIUGcYwIGo2QLGkCSTlkQiTYBRkukpuAJcMVB6kFDyYxwtpBE7mZD2E+3550h/0bk+tlVf3Ttpnp41m/aQZnoVmh4V7R1VOHv0RQXrbPG202vV2MMUAOG4YeQAvRioJV0QzT4KHmtKLCeV6BQzrNhCoCLNUMSp7h9yzFAfh/klmJFSmjGz8uUxNj4og0duAWiHsfUj+BSPUmsX0mf2DzzPGghdmPd4piqWMc8HqiYyrCmG5HJoeRE9oVq+rK2qmhWq94yIF+XqwD4KXz4FBNmE0NpU7LUgZSDUe9qvV7q2E4qPGGaM9pfhOeSJW8vUVaL/ilrJPtyL6n8HaCg1nRd5ePzW5KubSRYYihUArE5XHCE6fT8WxUqP5Wg71yNY3IerWQImYMKiwUJ6hImmGPjo+az1gr7+KjVLQzxcjU+p8ywA3N9vHUmiadP4U3UyubcwATdTKxF9O+6L3n2GuW2GzYUZpLJeWmVKpfB8Eq9XKnxHp5W0Evu6ttxwLe1Panu23YgUKa1SIq6XUJ8XMfFn1TJvxKbNwrAHe/X9ntEtjKMzgiFoUum1NXfsXry/Yf92vtbQHBwJjL8zWqRJFBbflkrJJKeJxI0LXlV+iFoiv0ymtuI2p5GUUFDdB3VoU5LdA3dpv6M8Pvw==
Gn5j0Xs3Tk6eV8Jz